180 related articles for article (PubMed ID: 19944035)
21. [Cost of medications in the oncology sector in the context of health economics].
Walter E; Batista A
Wien Med Wochenschr; 2008; 158(7-8):227-33. PubMed ID: 18500477
[TBL] [Abstract][Full Text] [Related]
22. Economic burden of metastatic bone disease in the U.S.
Schulman KL; Kohles J
Cancer; 2007 Jun; 109(11):2334-42. PubMed ID: 17450591
[TBL] [Abstract][Full Text] [Related]
23. Economic cost of Guillain-Barré syndrome in the United States.
Frenzen PD
Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
[TBL] [Abstract][Full Text] [Related]
24. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
25. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
Wolfenstetter SB
Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
[TBL] [Abstract][Full Text] [Related]
26. [Economic burden of cancer in South Korea for the year 2005].
Kim J; Hahm MI; Park EC; Park JH; Park JH; Kim SE; Kim SG
J Prev Med Public Health; 2009 May; 42(3):190-8. PubMed ID: 19491563
[TBL] [Abstract][Full Text] [Related]
27. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
Joyce AT; Smith P; Khandker R; Melin JM; Singh A
J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658
[TBL] [Abstract][Full Text] [Related]
28. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
29. Anti-hypertensive drug utilization in Continental Portugal (1999-2004).
Furtado C; Pinto M
Rev Port Cardiol; 2006 Mar; 25(3):273-92. PubMed ID: 16789402
[TBL] [Abstract][Full Text] [Related]
30. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
[TBL] [Abstract][Full Text] [Related]
31. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
32. Acute coronary syndromes in Europe: 1-year costs and outcomes.
Taylor MJ; Scuffham PA; McCollam PL; Newby DE
Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
[TBL] [Abstract][Full Text] [Related]
33. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.
Sasser AC; Rousculp MD; Birnbaum HG; Oster EF; Lufkin E; Mallet D
Womens Health Issues; 2005; 15(3):97-108. PubMed ID: 15894195
[TBL] [Abstract][Full Text] [Related]
34. The economic burden of prostate cancer.
Roehrborn CG; Black LK
BJU Int; 2011 Sep; 108(6):806-13. PubMed ID: 21884356
[TBL] [Abstract][Full Text] [Related]
35. The cost of the district hospital: a case study in Malawi.
Mills AJ; Kapalamula J; Chisimbi S
Bull World Health Organ; 1993; 71(3-4):329-39. PubMed ID: 8324852
[TBL] [Abstract][Full Text] [Related]
36. The costs of cancer to a major employer in the United States: a case-control analysis.
Barnett A; Birnbaum H; Cremieux PY; Fendrick AM; Slavin M
Am J Manag Care; 2000 Nov; 6(11):1243-51. PubMed ID: 11185849
[TBL] [Abstract][Full Text] [Related]
37. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
[TBL] [Abstract][Full Text] [Related]
38. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
39. Urologic diseases in America Project: analytical methods and principal findings.
Litwin MS; Saigal CS; Yano EM; Avila C; Geschwind SA; Hanley JM; Joyce GF; Madison R; Pace J; Polich SM; Wang M;
J Urol; 2005 Mar; 173(3):933-7. PubMed ID: 15711342
[TBL] [Abstract][Full Text] [Related]
40. The direct and indirect costs of cardiovascular disease in South Africa in 1991.
Pestana JA; Steyn K; Leiman A; Hartzenberg GM
S Afr Med J; 1996 Jun; 86(6):679-84. PubMed ID: 8764427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
